Company intelligence / Profile preview

Rolland

Suresnes, France

Ownership: Private
Development stage: Other

Overview

Laboratoires Rolland was a French pharmaceutical company that became a significant subsidiary of the Servier Group. Historically, the company was involved in the development and marketing of several metabolic and cardiovascular drugs, most notably being associated with the early commercialization of benfluorex (Mediator). Following its integration into Servier, the Rolland name was primarily used as a marketing and legal entity for specific product lines in the French market. The company's operations have since been fully absorbed into the parent organization's global pharmaceutical business.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Rolland.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rolland.

Explore the full profile